Rivaroxaban

Results: 251



#Item
1*** Drug Safety Alert *** Xarelto (Rivaroxaban) Tablets FDA MedWatch - August 2013 Safety Labeling Changes with revisions to Prescribing Information [PostedThe MedWatch August 2013 Safety Labeling Changes po

*** Drug Safety Alert *** Xarelto (Rivaroxaban) Tablets FDA MedWatch - August 2013 Safety Labeling Changes with revisions to Prescribing Information [PostedThe MedWatch August 2013 Safety Labeling Changes po

Add to Reading List

Source URL: www.icsi.org

- Date: 2013-10-22 15:16:09
    2Microsoft Word - frommtg draft uspi xarelto rivaroxaban.doc

    Microsoft Word - frommtg draft uspi xarelto rivaroxaban.doc

    Add to Reading List

    Source URL: www.xareltohcp.com

    - Date: 2016-09-08 14:47:07
      3MEDICATION GUIDE XARELTO® (zah-REL-toe) (rivaroxaban) tablets Read this Medication Guide before you start taking XARELTO and each time you get a refill. There may be new information. This Medication Guide does not take

      MEDICATION GUIDE XARELTO® (zah-REL-toe) (rivaroxaban) tablets Read this Medication Guide before you start taking XARELTO and each time you get a refill. There may be new information. This Medication Guide does not take

      Add to Reading List

      Source URL: www.fda.gov

        4Atrial Fibrillation (AFib) Treatment Adherence Following your treatment plan will reduce your risk of AFib-related stroke. it can enter the bloodstream and cause a stroke. A stroke means

        Atrial Fibrillation (AFib) Treatment Adherence Following your treatment plan will reduce your risk of AFib-related stroke. it can enter the bloodstream and cause a stroke. A stroke means

        Add to Reading List

        Source URL: resources.hrsonline.org

        Language: English - Date: 2015-09-09 14:29:44
        5QuarterWatch Monitoring FDA MedWatch Reports Why Reports of Serious Adverse Drug Events Continue to Grow October 3, 2012 Data from 2012 Quarter 1

        QuarterWatch Monitoring FDA MedWatch Reports Why Reports of Serious Adverse Drug Events Continue to Grow October 3, 2012 Data from 2012 Quarter 1

        Add to Reading List

        Source URL: www.ismp.org

        Language: English - Date: 2012-10-03 12:53:27
        6SPECIAL AUTHORIZATION REQUEST FORM The Newfoundland and Labrador Prescription Drug Program (NLPDP) Venous Thromboembolism (VTE) Prevention Following Surgery Pharmaceutical Services Department of Health and Community Serv

        SPECIAL AUTHORIZATION REQUEST FORM The Newfoundland and Labrador Prescription Drug Program (NLPDP) Venous Thromboembolism (VTE) Prevention Following Surgery Pharmaceutical Services Department of Health and Community Serv

        Add to Reading List

        Source URL: www.health.gov.nl.ca

        Language: English - Date: 2016-02-02 08:19:44
        7SPECIAL AUTHORIZATION REQUEST FORM The Newfoundland and Labrador Prescription Drug Program (NLPDP) Request for Coverage of Novel Oral Anticoagulant (NOAC) for Atrial Fibrillation (AF) Pharmaceutical Services Department o

        SPECIAL AUTHORIZATION REQUEST FORM The Newfoundland and Labrador Prescription Drug Program (NLPDP) Request for Coverage of Novel Oral Anticoagulant (NOAC) for Atrial Fibrillation (AF) Pharmaceutical Services Department o

        Add to Reading List

        Source URL: www.health.gov.nl.ca

        Language: English - Date: 2015-06-23 07:06:40
        8April 21st, 2015 Kits for which Material Safety Data Sheets are not required The kits listed below are not labelled as hazardous. Considering the Regulation (EC) N° and the OSHA regulations 29 CFRg

        April 21st, 2015 Kits for which Material Safety Data Sheets are not required The kits listed below are not labelled as hazardous. Considering the Regulation (EC) N° and the OSHA regulations 29 CFRg

        Add to Reading List

        Source URL: extranet.stago.com

        Language: English - Date: 2015-07-17 16:22:49
        9SPECIAL AUTHORIZATION REQUEST Dabigatran(Pradaxa®), Rivaroxaban(Xarelto®), Apixaban(Eliquis®) Fax requests toOR mail requests to PEI Pharmacare, P.O. Box 2000, Charlottetown, PE, C1A 7N8 SECTION 1 –

        SPECIAL AUTHORIZATION REQUEST Dabigatran(Pradaxa®), Rivaroxaban(Xarelto®), Apixaban(Eliquis®) Fax requests toOR mail requests to PEI Pharmacare, P.O. Box 2000, Charlottetown, PE, C1A 7N8 SECTION 1 –

        Add to Reading List

        Source URL: www.gov.pe.ca

        Language: English - Date: 2015-04-28 07:57:44
          10DecemberSTROKE PREVENTION IN ATRIAL FIBRILLATION: ROLE OF THE NEWER ORAL ANTICOAGULANTS

          DecemberSTROKE PREVENTION IN ATRIAL FIBRILLATION: ROLE OF THE NEWER ORAL ANTICOAGULANTS

          Add to Reading List

          Source URL: www.medicalpharmacies.com

          Language: English - Date: 2014-12-05 13:08:19